Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform.

Schmitz JM, Mooney ME, Moeller FG, Stotts AL, Green C, Grabowski J.

Drug Alcohol Depend. 2008 Apr 1;94(1-3):142-50. doi: 10.1016/j.drugalcdep.2007.11.004. Epub 2007 Dec 27.

2.

Contingency management and levodopa-carbidopa for cocaine treatment: a comparison of three behavioral targets.

Schmitz JM, Lindsay JA, Stotts AL, Green CE, Moeller FG.

Exp Clin Psychopharmacol. 2010 Jun;18(3):238-44. doi: 10.1037/a0019195.

3.

A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone.

Schmitz JM, Green CE, Stotts AL, Lindsay JA, Rathnayaka NS, Grabowski J, Moeller FG.

Drug Alcohol Depend. 2014 Mar 1;136:100-7. doi: 10.1016/j.drugalcdep.2013.12.015. Epub 2014 Jan 3.

4.

Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.

McDowell D, Nunes EV, Seracini AM, Rothenberg J, Vosburg SK, Ma GJ, Petkova E.

Drug Alcohol Depend. 2005 Nov 1;80(2):209-21.

PMID:
15913920
5.

Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: two double-blind, randomized, clinical trials.

Mooney ME, Schmitz JM, Moeller FG, Grabowski J.

Drug Alcohol Depend. 2007 May 11;88(2-3):214-23. Epub 2006 Nov 28.

6.

High-dose naltrexone therapy for cocaine-alcohol dependence.

Schmitz JM, Lindsay JA, Green CE, Herin DV, Stotts AL, Moeller FG.

Am J Addict. 2009 Sep-Oct;18(5):356-62. doi: 10.3109/10550490903077929.

7.

Safety and efficacy of L-tryptophan and behavioral incentives for treatment of cocaine dependence: a randomized clinical trial.

Jones HE, Johnson RE, Bigelow GE, Silverman K, Mudric T, Strain EC.

Am J Addict. 2004 Oct-Dec;13(5):421-37.

PMID:
15764421
8.

Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial.

Carroll KM, Fenton LR, Ball SA, Nich C, Frankforter TL, Shi J, Rounsaville BJ.

Arch Gen Psychiatry. 2004 Mar;61(3):264-72.

9.

Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.

Levin FR, Evans SM, Brooks DJ, Garawi F.

Drug Alcohol Depend. 2007 Feb 23;87(1):20-9. Epub 2006 Aug 22.

PMID:
16930863
10.

A randomized, controlled trial of combined cognitive-behavioral therapy plus prize-based contingency management for cocaine dependence.

Petitjean SA, Dürsteler-MacFarland KM, Krokar MC, Strasser J, Mueller SE, Degen B, Trombini MV, Vogel M, Walter M, Wiesbeck GA, Farronato NS.

Drug Alcohol Depend. 2014 Dec 1;145:94-100. doi: 10.1016/j.drugalcdep.2014.09.785. Epub 2014 Oct 16.

11.

A controlled trial of the adjunct use of D-cycloserine to facilitate cognitive behavioral therapy outcomes in a cocaine-dependent population.

Kennedy AP, Gross RE, Whitfield N, Drexler KP, Kilts CD.

Addict Behav. 2012 Aug;37(8):900-7. doi: 10.1016/j.addbeh.2012.03.008. Epub 2012 Mar 13.

12.

A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence.

Johnson BA, Roache JD, Ait-Daoud N, Javors MA, Harrison JM, Elkashef A, Mojsiak J, Li SH, Bloch DA.

Drug Alcohol Depend. 2006 Oct 1;84(3):256-63. Epub 2006 May 2.

PMID:
16631323
13.

Randomized clinical trial examining duration of voucher-based reinforcement therapy for cocaine abstinence.

Kirby KC, Carpenedo CM, Dugosh KL, Rosenwasser BJ, Benishek LA, Janik A, Keashen R, Bresani E, Silverman K.

Drug Alcohol Depend. 2013 Oct 1;132(3):639-45. doi: 10.1016/j.drugalcdep.2013.04.015. Epub 2013 May 13.

14.

A randomized placebo-controlled trial of gabapentin for cocaine dependence.

Bisaga A, Aharonovich E, Garawi F, Levin FR, Rubin E, Raby WN, Nunes EV.

Drug Alcohol Depend. 2006 Feb 28;81(3):267-74. Epub 2005 Oct 5.

PMID:
16169160
15.

A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence.

Kampman KM, Pettinati HM, Lynch KG, Spratt K, Wierzbicki MR, O'Brien CP.

Drug Alcohol Depend. 2013 Nov 1;133(1):94-9. doi: 10.1016/j.drugalcdep.2013.05.026. Epub 2013 Jun 28.

16.

A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription.

Dürsteler-MacFarland KM, Farronato NS, Strasser J, Boss J, Kuntze MF, Petitjean SA, Bürki C, Wiesbeck GA.

J Clin Psychopharmacol. 2013 Feb;33(1):104-8. doi: 10.1097/JCP.0b013e31827bfff4.

PMID:
23277248
17.

Topiramate for the treatment of cocaine addiction: a randomized clinical trial.

Johnson BA, Ait-Daoud N, Wang XQ, Penberthy JK, Javors MA, Seneviratne C, Liu L.

JAMA Psychiatry. 2013 Dec;70(12):1338-46. doi: 10.1001/jamapsychiatry.2013.2295.

PMID:
24132249
18.

A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence.

Kampman KM, Lynch KG, Pettinati HM, Spratt K, Wierzbicki MR, Dackis C, O'Brien CP.

Drug Alcohol Depend. 2015 Oct 1;155:105-10. doi: 10.1016/j.drugalcdep.2015.08.005. Epub 2015 Aug 14.

PMID:
26320827
19.

Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology.

Mooney LJ, Nielsen S, Saxon A, Hillhouse M, Thomas C, Hasson A, Stablein D, McCormack J, Lindblad R, Ling W.

Contemp Clin Trials. 2013 Mar;34(2):196-204. doi: 10.1016/j.cct.2012.11.002. Epub 2012 Nov 16.

20.

The role of homework in cognitive-behavioral therapy for cocaine dependence.

Gonzalez VM, Schmitz JM, DeLaune KA.

J Consult Clin Psychol. 2006 Jun;74(3):633-7.

PMID:
16822120
Items per page

Supplemental Content

Write to the Help Desk